QTTB — Q32 Bio Inc. | ScreenerHero

QTTBQ32 Bio Inc.

NAS · US · Healthcare · Biotechnology · q32bio.com

6.935USD+19.57%Mkt Cap: 120.48M USDP/E: 2.56Last update: 2026-05-26

Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immu…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap120.48M USD

Enterprise Value56.16M USD

Revenue (TTM)53.74M USD

Gross Profit38.49M USD

Net Income (TTM)29.82M USD

Revenue/Share4.206 USD

Last Price6.935 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees22

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)2.56

P/E (Forward)-1.03

PEG—

EV/EBITDA2.58

EV/Revenue1.05

P/S1.74

P/B1.74

EPS (TTM)2.78

EPS (Forward)-5.36

52W Range

1.34583% of range8.045

52W High8.045 USD

52W Low1.345 USD

Profitability

Gross Margin71.62%

Oper. Margin39.84%

EBITDA Margin40.51%

Profit Margin55.49%

ROE70.98%

ROA48.27%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-33.54M USD

CapEx (TTM)—

FCF Margin18.37%

FCF Yield8.19%

Net Debt-37.10M USD

Net Debt/EBITDA-1.70

Balance Sheet

Debt/Equity0.37

Current Ratio5.36

Quick Ratio4.81

Book Value/Sh3.166 USD

Cash/Share2.993 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:18

Split DateMar 26, 2024

Analyst Consensus

Rating1.5 (Buy)

Target (Mean)14.33 USD

Target Range10.00 USD – 20.00 USD

# Analysts3

Ownership

Shares Out.16.96M

Float9.69M

Insiders3.93%

Institutions59.75%

Short Interest

Short Ratio1.8d

Short % Float8.01%

Short % Out.3.85%

Shares Short652.82K

Short (prev mo.)411.01K

Technical

SMA 506.011 (+15.4%)

SMA 2003.745 (+85.2%)

Beta-1.27

S&P 52W Chg28.31%

Avg Vol (30d)308.49K

Avg Vol (10d)240.36K

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—